SMSbiotech

SMSbiotech is a pre-clinical, late-stage biotechnology company based in San Diego, California. Their core focus is on developing innovative cell-based therapies for regenerative medicine and drug discovery. SMSbiotech has discovered and patented a new type of adult stem cell, the Small Mobile Stem Cell. These cells offer unique properties for therapeutic applications. They are developing therapies using SMS cells to promote tissue repair and regeneration in conditions like chronic wounds and lung diseases. SMSbiotech utilizes their SMS cell platform to test the safety and efficacy of potential new drugs. Their lead products include SCTE, for lung therapy, and PEC-2S, for skin wound healing, among others. Many of the products in their pipeline are in the late stages of pre-clinical development, indicating significant progress toward potential clinical trials.

Jobs: